In our report for the period ended Dec. 31, 2009 that was released this morning, we updated investors on the significant progress achieved by Safeguard…
Posted by
Safeguard Scientifics’ partner company Clarient (NASDAQ: CLRT) reported its fourth quarter (Dec. 31, 2009) and full-year 2009 financial results this afternoon. Clarient began 2010 with…
Posted by
Safeguard Scientifics’ strategy is to deploy capital in growth-stage companies in attractive sectors of the life sciences and technology industries. Within life sciences, we target…
Posted by
Molecular Biometrics, Inc., one of Safeguard Scientifics’ Life Sciences partner companies, raised another $12.5 million of capital. The new capital will support three big goals.…
Posted by
James A. Datin, EVP and Managing Director of Safeguard Scientifics‘ Life Sciences Group, was recently interviewed by FierceBiotech, a leading industry online publication, about biotech…
Posted by
Safeguard Scientifics’ partner company Avid Radiopharmaceuticals was invited to present its technology and growth strategy at the prestigious J.P. Morgan 28th Annual Healthcare Conference in…
Posted by
Bruce Bigelow of Xconomy San Diego highlights Advanced BioHealing’s (ABH) commercial success with Dermagraft in his article. Bigelow details the success of Dermagraft and ABH’s…
Posted by
